Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kadmon
Pharma
J&J, AbbVie's Imbruvica is first drug to treat kids with cGVHD
Johnson & Johnson and AbbVie’s Imbruvica has gained its first pediatric nod. This one is for chronic graft-versus-host disease.
Kevin Dunleavy
Aug 25, 2022 9:37am
Former Kadmon consultant pleads guilty to insider trading
Aug 23, 2022 2:42pm
SEC comes down on former AZ exec for alleged insider trading
May 31, 2022 5:50pm
Kadmon adviser enriched himself during $1.9B Sanofi deal: SEC
May 25, 2022 10:45am
Rezurock shows link between organ responses and patient outcomes
Apr 21, 2022 8:57am
Sanofi cuts 2 dozen Kadmon staffers after $1.9B buyout
Apr 6, 2022 10:26am
